INSPRA

This brand name is authorized in United States. It is also authorized in Australia, Austria, Canada, Croatia, Cyprus, Estonia, Finland, France, Germany, Hong Kong SAR China, Ireland, Israel, Italy, Lithuania, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, South Africa, Spain, Turkey, UK.

Active ingredients

The drug INSPRA contains one active pharmaceutical ingredient (API):

1	Eplerenone UNII 6995V82D0B - EPLERENONE
	Eplerenone has relative selectivity in binding to recombinant human mineralocorticoid receptors compared to its binding to recombinant human glucocorticoid, progesterone and androgen receptors. Eplerenone prevents the binding of aldosterone, a key hormone in the renin-angiotensin-aldosterone-system (RAAS), which is involved in the regulation of blood pressure and the pathophysiology of CV disease.
	Read more about Eplerenone

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
INSPRA Film-coated tablet	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C03DA04	Eplerenone	C Cardiovascular system → C03 Diuretics → C03D Potassium-sparing agents → C03DA Aldosterone antagonists
Discover more medicines within C03DA04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	8879H, 8880J
CA	Health Products and Food Branch	02323052, 02323060
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00136780, 00136834, 00136946, 00137561, 01004951, 01004974, 01016871, 01016894, 01129262, 02949211, 02949228, 02949234, 02949286, 02949292, 03268909, 03268921, 03268950, 03269116, 03270355, 03270378, 03270409, 04511105, 04511111, 04511128, 04513682, 06108098, 06111315, 06111321, 06111344, 06489114, 07586799, 07586813, 07586859, 07770586, 09236684, 09236690, 09923982, 10783256, 10957673, 11149024, 11149030, 11230200, 11519722, 11709635, 13416050, 13416067, 13416073, 13416104, 13416110, 13416127, 14357119, 15376768, 15376774, 15376797, 15376805, 15568255, 15568261, 16812303, 17448064, 17602140
EE	Ravimiamet	1206694, 1206830, 1206841, 1206852, 1206863, 1206874, 1206885, 1206896, 1206908, 1206919, 1206920, 1206931, 1206942, 1206953, 1206964, 1206975
ES	Centro de información online de medicamentos de la AEMPS	66355, 66356
FI	Lääkealan turvallisuus- ja kehittämiskeskus	018926, 018998
FR	Base de données publique des médicaments	65681906, 66335558
GB	Medicines & Healthcare Products Regulatory Agency	175669, 175671, 381408, 84774, 84799
HK	Department of Health Drug Office	53030, 53031
HR	Agencija za lijekove i medicinske proizvode	HR-H-244093147, HR-H-730921224
IE	Health Products Regulatory Authority	30507, 30542, 30557
IL	מִשְׂרַד הַבְּרִיאוּת	4958, 4959
IT	Agenzia del Farmaco	037298092, 037298217
LT	Valstybinė vaistų kontrolės tarnyba	1021524, 1021525, 1021526, 1021527, 1021528, 1021529, 1021530, 1021531, 1021532, 1021533, 1021534, 1021535, 1021536, 1021537, 1021538, 1021539, 1024337, 1024338, 1024339, 1024340, 1024341, 1024342, 1024343, 1024344, 1024345, 1024346, 1033999, 1034000, 1061470, 1061471
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	268M2004
NL	Z-Index G-Standaard, PRK	73431, 73458
NZ	Medicines and Medical Devices Safety Authority	11534, 11536
PL	Rejestru Produktów Leczniczych	100162343, 100162366
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W67260002, W67260004, W67260005, W67260006, W67260007, W67260008, W67260009, W67260010, W67260011, W67260012, W67260013, W67260014, W67261002, W67261004, W67261005, W67261006, W67261007, W67261008, W67261009, W67261010, W67261011, W67261012, W67261013, W67261014
SG	Health Sciences Authority	13048P, 13049P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699532094001, 8699532094018
US	FDA, National Drug Code	0025-1710, 0025-1720
ZA	Health Products Regulatory Authority	A39/6.4/0106, A39/6.4/0107